The MMAC1 Tumor Suppressor Phosphatase Inhibits Phospholipase C and Integrin-Linked Kinase Activity

Total Page:16

File Type:pdf, Size:1020Kb

The MMAC1 Tumor Suppressor Phosphatase Inhibits Phospholipase C and Integrin-Linked Kinase Activity Oncogene (2000) 19, 200 ± 209 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc The MMAC1 tumor suppressor phosphatase inhibits phospholipase C and integrin-linked kinase activity Alyssa M Morimoto1, Michael G Tomlinson1, Kaname Nakatani2, Joseph B Bolen3, Richard A Roth2 and Ronald Herbst*,1 1Department of Cell Signaling, DNAX Research Institute, 901 California Ave, Palo Alto, California, CA 94304, USA; 2Department of Molecular Pharmacology, Stanford University School of Medicine, Stanford, California, CA 94305, USA; 3Department of Oncology, Hoechst Marion Roussel, Bridgewater, New Jersey, NJ 08807, USA Loss of the tumor suppressor MMAC1 has been shown Introduction to be involved in breast, prostate and brain cancer. Consistent with its identi®cation as a tumor suppressor, MMAC1 (also known as PTEN or TEP-1) is mutated at expression of MMAC1 has been demonstrated to reduce a high frequency in brain, breast, and prostate tumors cell proliferation, tumorigenicity, and motility as well as as well as in melanomas and endometrial carcinomas, aect cell±cell and cell±matrix interactions of malignant (Guldberg et al., 1997; Kong et al., 1997; Li and Sun, human glioma cells. Subsequently, MMAC1 was shown 1997; Li et al., 1997; Steck et al., 1997). These to have lipid phosphatase activity towards PIP3 and observations suggest that MMAC1 acts as a tumor protein phosphatase activity against focal adhesion suppressor in multiple tissues. Indeed, subsequent kinase (FAK). The lipid phosphatase activity of studies showed that reintroduction of this gene into MMAC1 results in decreased activation of the PIP3- human glioma cells reduced cell growth, tumorigenicity dependent, anti-apoptotic kinase, AKT. It is thought that in nude mice, and aected motility and cell ± cell this inhibition of AKT culminates with reduced glioma interactions, demonstrating that MMAC1 represents a cell proliferation. In contrast, MMAC1's eects on cell bone ®de tumor suppressor (Furnari et al., 1997; Cheney motility, cell ± cell and cell ± matrix interactions are et al., 1998; Tamura et al., 1998; Morimoto et al., 1999). thought to be due to its protein phosphatase activity Interestingly, germ line mutations in MMAC1 have also towards FAK. However, recent studies suggest that the been linked to the multiple hamartomatous predisposi- lipid phosphatase activity of MMAC1 correlates with its tion syndromes, Cowden's disease and Bannayan ± ability to be a tumor suppressor. The high rate of Zonana. These syndromes are also associated with mutation of MMAC1 in late stage metastatic tumors increased susceptibility to breast and thyroid cancer suggests that eects of MMAC1 on motility, cell ± cell (Liaw et al., 1997; Marsh et al., 1997). and cell ± matrix interactions are due to its tumor Sequence analysis of MMAC1 indicated that this suppressor activity. Therefore the lipid phosphatase gene encodes motifs conserved in dual speci®city activity of MMAC1 may aect PIP3 dependent signaling phosphatases (Li and Sun, 1997; Li et al., 1997; Steck pathways and result in reduced motility and altered cell ± et al., 1997). MMAC1 has been shown to possess cell and cell ± matrix interactions. We demonstrate here protein phosphatase activity towards focal adhesion that expression of MMAC1 in human glioma cells kinase (FAK) (Tamura et al., 1998) and lipid reduced intracellular levels of inositol trisphosphate and phosphatase activity toward phosphatidylinositol 2+ inhibited extracellular Ca in¯ux, suggesting that 3,4,5-trisphosphate (PIP3) (Maehama et al., 1998). MMAC1 aects the phospholipase C signaling pathway. However, it appears that the lipid phosphatase activity In addition, we show that MMAC1 expression inhibits of MMAC1 correlates with tumor suppression (Myers integrin-linked kinase activity. Furthermore, we show et al., 1998). that these eects require the catalytic activity of Many signaling molecules directly bind PIP3 through MMAC1. Our data thus provide a link of MMAC1 to pleckstrin homology (PH) domains (Corvera and PIP3 dependent signaling pathways that regulate cell ± Czech, 1998) and could thus be aected by reduced matrix and cell ± cell interactions as well as motility. levels of PIP3 due to expression of MMAC1. The Lastly, we demonstrate that AKT3, an isoform of AKT binding of PIP3 to PH domain-containing proteins such highly expressed in the brain, is also a target for as AKT, phospholipase C (PLC) and integrin linked MMAC1 repression. These data suggest an important kinase (ILK) is thought to facilitate membrane role for AKT3 in glioblastoma multiforme. We therefore targeting and induce conformational changes that propose that repression of multiple PIP3 dependent result directly, or indirectly, in activation (Aoki et al., signaling pathways may be required for MMAC1 to 1998; Delcommenne et al., 1998; Falasca et al., 1998). act as a tumor suppressor. Oncogene (2000) 19, 200 ± Recent studies have shown that PIP3 levels are 209. indeed higher in cells lacking MMAC1 (Haas-Kogan et al., 1998; Stambolic et al., 1998). In addition, lack of Keywords: MMAC1; PTEN; TEP1; ILK; PLC endogenous MMAC1 expression correlated with elevated levels of activated AKT1 (Haas-Kogan et al., 1998; Myers et al., 1998; Stambolic et al., 1998; Suzuki et al., 1998), and ectopic MMAC1 expression resulted in decreased levels of activated AKT and *Correspondence: R Herbst phosphorylated BAD protein (Myers et al., 1997; Wu Received 6 May 1999; revised 30 September 1999; accepted 13 October 1999 et al., 1998a). Therefore, these results are consistent MMAC1 inhibits PLC and ILK AM Morimoto et al 201 with a model in which MMAC1 reduces AKT activity and motility of human glioma cells (Li et al., 1997; and thus increases apoptosis, resulting in tumor Steck et al., 1997; Furnari et al., 1997; Cheney et al., suppression. However, there are a number of observa- 1998; Tamura et al., 1998; Morimoto et al., 1999). tions that suggest that MMAC1 does not inhibit tumor The lipid phosphatase activity of MMAC1 appears to suppression solely through repression of the AKT result in inhibition of AKT1 activity and a growth signaling pathway. suppression phenotype (Haas-Kogan et al., 1998; Expression of MMAC1 in malignant human glioma Stambolic et al., 1998; Suzuki et al., 1998). The cells not only inhibits cell proliferation and tumor- protein phosphatase activity results in FAK depho- igenicity, but also aects motility and cell ± cell and sphorylation which is thought to then cause decreased cell ± matrix interactions (Furnari et al., 1997; Cheney cell motility and cell ± matrix interaction (Tamura et et al., 1998; Tamura et al., 1998; Morimoto et al., al., 1998). However, it appears that the lipid 1999). In addition, loss of MMAC1 correlates with the phosphatase activity of MMAC1 correlates with progression of tumors to a metastatic state, suggesting tumor suppressor activity (Myers et al., 1998). Thus that the tumor suppressor activity of MMAC1 aects far, the AKT signaling pathway has not been linked cell motility and/or cell ± matrix or cell ± cell interac- to either cell ± cell, cell ± matrix interactions or cell tions in vivo. As the AKT signaling pathway has not motility. This suggested that other PIP3 dependent been shown to aect cell ± matrix and cell ± cell signaling pathways may be inhibited by the tumor interactions or cell motility, these observations suggest suppressor activity of MMAC1 resulting in decreased that repression of PIP3 regulated signaling pathways cell motility and/or altered cell ± matrix and cell ± cell distinct from AKT may contribute to the ability of interactions. MMAC1 to suppress tumor formation. We therefore examined whether MMAC1 expres- In contrast to the AKT signaling pathway, both sion aects signaling pathways that are involved in the phospholipase C (PLC) and the integrin linked such processes and are also regulated by PIP3. One kinase (ILK) signaling pathways regulate motility as such candidate is the phospholipase C (PLC) well as cell ± cell and cell ± matrix interactions. The signaling pathway. PLC activation generates inositol PLC signaling pathway has been linked to the trisphos-phate (IP3) and diacylglycerol (DAG) which motility of human glioma cells (Kyoshmomn et al., result in a ¯ux of intracellular calcium and 1999). Similarly, integrin linked kinase (ILK) aects stimulation of protein kinase C (PKC) in a PIP3 cell motility and cell ± cell and cell ± matrix interac- dependent manner, respectively (Falasca et al., 1998; tions. Overexpression of this PIP3 regulated kinase is Rameh et al., 1998; Rhee et al., 1997). In addition, also sucient to induce tumorigenicity in vivo the PLC signaling pathway has been linked to the (Hannigan et al., 1996; Radeva et al., 1997). As motility of human glioma cells (Khoshyomn et al., both ILK and PLC are PIP3 dependent enzymes 1999). We therefore examined whether expression of (Hannigan et al., 1996; Falasca et al., 1998), they MMAC1 aected the intracellular levels of IP3 in represent potential downstream targets for MMAC1 human glioma cells. regulation. As such, MMAC1 could aect tumor cell As a control, we ®rst examined whether IP3 levels motility, cell ± cell and cell ± matrix interactions are sensitive to the PI3 kinase inhibitor, LY294002, in through the inhibition of these enzymes and their U373 cells. Asynchronously growing U373 control cells signaling pathways. were treated with vehicle or the PI3 kinase inhibitor, We show here that reintroduction of MMAC1 into LY294002, and the amount of IP3 present in the lysates human glioblastoma cells reduces extracellular Ca2+ was determined. As shown in Figure 1a, the levels of in¯ux, intracellular inositol trisphosphate (IP3) levels, IP3 were reduced by over 50% when cells were treated and ILK activity. These results thus provide a link with LY294002. To determine whether MMAC1 between MMAC1 and PIP3 dependent signaling similarly aects IP3 levels, we also examined IP3 levels pathways that aect cell motility, cell ± cell and cell ± in cells expressing WT MMAC1 or a catalytically matrix interactions. As the PLC and the ILK signaling inactive form of MMAC1, C124S MMAC1 (Figure pathways are also involved in mitogenesis (Rhee et al., 1b).
Recommended publications
  • (PDE 1 B 1) Correlates with Brain Regions Having Extensive Dopaminergic Innervation
    The Journal of Neuroscience, March 1994, 14(3): 1251-l 261 Expression of a Calmodulin-dependent Phosphodiesterase lsoform (PDE 1 B 1) Correlates with Brain Regions Having Extensive Dopaminergic Innervation Joseph W. Polli and Randall L. Kincaid Section on Immunology, Laboratory of Molecular and Cellular Neurobiology, National Institute on Alcohol Abuse and Alcoholism, Rockville, Maryland 20852 Cyclic nucleotide-dependent protein phosphorylation plays PDE implies an important physiological role for Ca2+-regu- a central role in neuronal signal transduction. Neurotrans- lated attenuation of CAMP-dependent signaling pathways mitter-elicited increases in cAMP/cGMP brought about by following dopaminergic stimulation. activation of adenylyl and guanylyl cyclases are downre- [Key words: CAMP, cyclase, striatum, dopamine, basal gulated by multiple phosphodiesterase (PDE) enzymes. In ganglia, DARPP-321 brain, the calmodulin (CaM)-dependent isozymes are the major degradative activities and represent a unique point of Cyclic nucleotides, acting as “second messengers”or via direct intersection between the cyclic nucleotide- and calcium effects, regulate a diverse array of neuronal functions, from ion (Ca*+)-mediated second messenger systems. Here we de- channel conductance to gene expression. Hydrolysis of 3’,5’- scribe the distribution of the PDEl Bl (63 kDa) CaM-depen- cyclic nucleotidesto 5’-nucleosidemonophosphates is the major dent PDE in mouse brain. An anti-peptide antiserum to this mechanismfor decreasingintracellular cyclic nucleotide levels. isoform immunoprecipitated -3O-40% of cytosolic PDE ac- This reaction is catalyzed by cyclic nucleotide phosphodiester- tivity, whereas antiserum to PDElA2 (61 kDa isoform) re- ase (PDE) enzymes that constitute a large superfamily (Beavo moved 60-70%, demonstrating that these isoforms are the and Reifsynder, 1990).
    [Show full text]
  • Serum 5-Nucleotidase by Theodore F
    J Clin Pathol: first published as 10.1136/jcp.7.4.341 on 1 November 1954. Downloaded from J. clin. Path. (1954), 7, 341. SERUM 5-NUCLEOTIDASE BY THEODORE F. DIXON AND MARY PURDOM t0o From the Biochemistry Department, the Institute of Orthopaedics, Stanmore, Middlesex (RECEIVED FOR PUBLICATION DECEMBER 8. 1953) Reis (1934, 1940, 1951) has demonstrated the add the molybdate solution, and dilute with washings to presence of alkaline phosphatase in various tissues 1 litre with water. specifically hydrolysing 5-nucleotidase such as Standard Phosphate Solution.-KH2PO4 0.02195 g., adenosine and inosine-5-phosphoric acids. The and 50 g. trichloracetic acid, made up to 1 litre. This enzyme has its optimum action at pH 7.8 and in all solution contains 0.02 mg. P in 4 ml. human tissues except intestinal mucosa its activity, at the physiological pH range, is much more Methods pronounced than that of the non-specific alkaline Non-specific alkaline phosphatase activity is high at phosphatase. Thus ossifying cartilage, one of the pH 9 towards phenylphosphate adenosine phosphate classical sites of high alkaline phosphatase activity, and glycerophosphate, in this decreasing order (cf. Reis, although very active against say phenyl phosphoric 1951). At pH 7.5, however, the total phosphatase acids at pH 9, is more active against adenosine-5- activity is equally low towards phenyl- or glycero-phos- phosphoric at pH 7.5. This finding suggested to phate -nd the higher activity towards adenosine-5- phosphate at this reaction is reasonably inferred to be Reis that the enzyme might play a part in calcifica- due to the specific 5-nucleotidase.
    [Show full text]
  • Phospholipase C-Related Catalytically Inactive Protein: a Novel Signaling Molecule for Modulating Fat Metabolism and Energy Expenditure
    Journal of Oral Biosciences 61 (2019) 65e72 Contents lists available at ScienceDirect Journal of Oral Biosciences journal homepage: www.elsevier.com/locate/job Review Phospholipase C-related catalytically inactive protein: A novel signaling molecule for modulating fat metabolism and energy expenditure * Takashi Kanematsu a, b, , Kana Oue a, c, Toshiya Okumura a, Kae Harada a, 1, Yosuke Yamawaki a, 2, Satoshi Asano a, Akiko Mizokami d, Masahiro Irifune c, Masato Hirata e a Department of Cellular and Molecular Pharmacology, Division of Basic Life Sciences, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8553, Japan b Department of Cell Biology and Pharmacology, Faculty of Dental Science, Kyushu University, Fukuoka, 812-8582, Japan c Department of Dental Anesthesiology, Division of Applied Life Sciences, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734- 8553, Japan d OBT Research Center, Faculty of Dental Science, Kyushu University, Fukuoka, 812-8582, Japan e Fukuoka Dental College, Fukuoka, 814-0193, Japan article info abstract Article history: Background: Overweight and obesity are defined as excessive or abnormal fat accumulation in adipose Received 16 March 2019 tissues, and increase the risk of morbidity in many diseases, including hypertension, dyslipidemia, type 2 Received in revised form diabetes, coronary heart disease, and stroke, through pathophysiological mechanisms. There is strong 17 April 2019 evidence that weight loss reduces the risk of metabolic syndrome by limiting blood pressure and Accepted 19 April 2019 improving the levels of serum triglycerides, total cholesterol, low-density lipoprotein-cholesterol, and Available online 15 May 2019 high-density lipoprotein-cholesterol. To date, several attempts have been made to develop effective anti- obesity medication or weight-loss drugs; however, satisfactory drugs for clinical use have not yet been Keywords: Adipose tissue developed.
    [Show full text]
  • Regulation of Calmodulin-Stimulated Cyclic Nucleotide Phosphodiesterase (PDE1): Review
    95-105 5/6/06 13:44 Page 95 INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 18: 95-105, 2006 95 Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): Review RAJENDRA K. SHARMA, SHANKAR B. DAS, ASHAKUMARY LAKSHMIKUTTYAMMA, PONNIAH SELVAKUMAR and ANURAAG SHRIVASTAV Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan, Cancer Research Division, Saskatchewan Cancer Agency, 20 Campus Drive, Saskatoon SK S7N 4H4, Canada Received January 16, 2006; Accepted March 13, 2006 Abstract. The response of living cells to change in cell 6. Differential inhibition of PDE1 isozymes and its environment depends on the action of second messenger therapeutic applications molecules. The two second messenger molecules cAMP and 7. Role of proteolysis in regulating PDE1A2 Ca2+ regulate a large number of eukaryotic cellular events. 8. Role of PDE1A1 in ischemic-reperfused heart Calmodulin-stimulated cyclic nucleotide phosphodiesterase 9. Conclusion (PDE1) is one of the key enzymes involved in the complex interaction between cAMP and Ca2+ second messenger systems. Some PDE1 isozymes have similar kinetic and 1. Introduction immunological properties but are differentially regulated by Ca2+ and calmodulin. Accumulating evidence suggests that the A variety of cellular activities are regulated through mech- activity of PDE1 is selectively regulated by cross-talk between anisms controlling the level of cyclic nucleotides. These Ca2+ and cAMP signalling pathways. These isozymes are mechanisms include synthesis, degradation, efflux and seque- also further distinguished by various pharmacological agents. stration of cyclic adenosine 3':5'-monophosphate (cAMP) and We have demonstrated a potentially novel regulation of PDE1 cyclic guanosine 3':5'- monophosphate (cGMP) within the by calpain.
    [Show full text]
  • Analyses of PDE-Regulated Phosphoproteomes Reveal Unique and Specific Camp-Signaling Modules in T Cells
    Analyses of PDE-regulated phosphoproteomes reveal unique and specific cAMP-signaling modules in T cells Michael-Claude G. Beltejara, Ho-Tak Laua, Martin G. Golkowskia, Shao-En Onga, and Joseph A. Beavoa,1 aDepartment of Pharmacology, University of Washington, Seattle, WA 98195 Contributed by Joseph A. Beavo, May 28, 2017 (sent for review March 10, 2017; reviewed by Paul M. Epstein, Donald H. Maurice, and Kjetil Tasken) Specific functions for different cyclic nucleotide phosphodiester- to bias T-helper polarization toward Th2, Treg, or Th17 pheno- ases (PDEs) have not yet been identified in most cell types. types (13, 14). In a few cases increased cAMP may even potentiate Conventional approaches to study PDE function typically rely on the T-cell activation signal (15), particularly at early stages of measurements of global cAMP, general increases in cAMP- activation. Recent MS-based proteomic studies have been useful dependent protein kinase (PKA), or the activity of exchange in characterizing changes in the phosphoproteome of T cells under protein activated by cAMP (EPAC). Although newer approaches various stimuli such as T-cell receptor stimulation (16), prosta- using subcellularly targeted FRET reporter sensors have helped glandin signaling (17), and oxidative stress (18), so much of the define more compartmentalized regulation of cAMP, PKA, and total Jurkat phosphoproteome is known. Until now, however, no EPAC, they have limited ability to link this regulation to down- information on the regulation of phosphopeptides by PDEs has stream effector molecules and biological functions. To address this been available in these cells. problem, we have begun to use an unbiased mass spectrometry- Inhibitors of cAMP PDEs are useful tools to study PKA/EPAC- based approach coupled with treatment using PDE isozyme- mediated signaling, and selective inhibitors for each of the 11 PDE – selective inhibitors to characterize the phosphoproteomes of the families have been developed (19 21).
    [Show full text]
  • Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis Through MDM2-Mediated Ubiquitination and Destabilization of P53
    Author Manuscript Published OnlineFirst on February 17, 2020; DOI: 10.1158/0008-5472.CAN-19-1912 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Hypomethylation-linked activation of PLCE1 impedes autophagy and promotes tumorigenesis through MDM2-mediated ubiquitination and destabilization of p53 Yunzhao Chen1,3*, Huahua Xin1*, Hao Peng1*, Qi Shi1, Menglu Li1, Jie Yu3, Yanxia Tian1, Xueping Han1, Xi Chen1, Yi Zheng4, Jun Li5, Zhihao Yang1, Lan Yang1, Jianming Hu1, Xuan Huang2, Zheng Liu2, Xiaoxi Huang2, Hong Zhou6, Xiaobin Cui1**, Feng Li1,2** 1 Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi 832002, China; 2 Department of Pathology and Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China; 3 The people's hospital of Suzhou National Hi-Tech District, Suzhou 215010, China; 4 Department of Gastroenterology, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi 832002, China; 5 Department of Ultrasound, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi 832002, China; 6 Bone Research Program, ANZAC Research Institute, The University of Sydney, Sydney, Australia. Running title: PLCE1 impedes autophagy via MDM2-p53 axis in ESCC *These authors contributed equally to this work. Corresponding authors: **Xiaobin Cui, Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi 832002, China. Phone: 86.0377.2850955; E-mail: [email protected]; **Feng Li, Department of Pathology and Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
    [Show full text]
  • Stimulation of Phospholipid Metabolism in Embryonic Muscle
    Proc. Natl. Acad. Sci. USA Vol. 76, No. 9, pp. 4474-4478, September 1979 Cell Biology Stimulation of phospholipid metabolism in embryonic muscle cells treated with phospholipase C (phospholipid synthesis/myogenesis) CLAUDIA KENT Department of Biochemistry, Purdue University, West Lafayette, Indiana 47907 Communicated by Edwin T. Mertz, May 29, 1979 ABSTRACT Phospholipid metabolism is dramatically MATERIALS AND METHODS stimulated in cultured myogenic cells in which cell fusion was inhibited with phospholipase C (phosphatidylcholine choline- Cultured Cells. Pectoral muscle from 11-day chicken em- phosphohydrolase; EC 3.1.4.3). Phospholipase C was active bryos was dissected, loose connective tissue was removed, and under the culture conditions as shown by the degradation of the muscle was minced into 1- to 2-mm fragments. Cells were exogenous phosphatidylcholine. Rates of incorporation of 32p; dissociated from the tissue fragments by trituration with a and [metkyl-3Hlcholine into lipids were about 5-fold greater in phospholipase-treated cells than in either untreated fusing cells pasteur pipette (8) in calcium- and magnesium-free Earle's salt or untreated cells prevented from fusing by-calcium deprivation. solution. The cell suspension was filtered through cheesecloth, The greatest stimulation in the phospholipase C-treated cultures preplated for 15 min (9), and then diluted with culture medium occurred with synthesis of phospai tlcholine and sphin- to 5 X 105 cells/ml. The cells were plated in tissue culture dishes gomyelin; synthesis of phosphatidyinositol and cardiolipin was precoated with rat tail collagen (10) at 8 ml of cell suspension not stimulated. Degradation of cellular [32Plphosphatidylcholine and appearance in the culture medium of the degradation per 100 mm dish.
    [Show full text]
  • Properties of an Acid Phosphatase in Pulmonary Surfactant (Lung Surfactant/Phosphatidate Phosphatase/Phosphatidylglycerol Phosphate) BRADLEY J
    Proc. Natl. Acad. Sci. USA Vol. 77, No. 2, pp. 808-811, February 1980 Biochemistry Properties of an acid phosphatase in pulmonary surfactant (lung surfactant/phosphatidate phosphatase/phosphatidylglycerol phosphate) BRADLEY J. BENSON Cardiovascular Research Institute, and the Department of Biochemistry, University of California, San Francisco, California 94143 Communicated by John A. Clements, November 5, 1979 ABSTRACT Lung surfactant, a lipid-protein complex pu- phatase (phosphatidate phosphohydrolase, EC 3.1.3.4) in in- rified from dog lungs, contains a highly active phosphomo- tracellular lamellar bodies. Spitzer et al. (13) also found the noesterase associated with it. This phosphatase is quite specific enzyme in their preparations of isolated lamellar bodies, for the hydrolysis of phosphatidic acid and 1-acyl-2-lysophos- phatidic acid. The enzyme possesses many of the characteristics whereas Garcia et al. (14) found no phosphatidate phosphatase of the microsomal enzyme, phosphatidate phosphohydrolase in their lamellar body preparations that they could not attribute (EC 3.1.3.4). In addition, we have shown that this enzyme will to microsomal contamination. Recently, however, Spitzer and also convert phosphatidylglycerol phosphate [1(3-sn-phospha- Johnston (15) demonstrated convincingly that the phosphatidate tidyl)sn-glycerol-1-PJ to phosphatidylglycerol [1{3-sn-phos- phosphatase in their lamellar body preparations was not con- phatidyl)sn-glycerolj and Pi. The phosphatidylglycerol phos- tamination from microsomes. Baranska and van Golde (16) phate was made available to the surfactant enzyme in a coupled assay by hydrolysis of cardiolipin [1(3-sn-phosphatidyl)3(3- reported that their preparations of lamellar bodies contained sn-phosphatidyl)sn-glycerolJ by stereospecific cleavage with no phospholipid biosynthetic enzymes that could not be at- phospholipase C (phosphatidylcholine cholinephosphohydro- tributed to microsomal contamination, although their studies lase, EC 3.1.4.3) from Bacillus cereus.
    [Show full text]
  • Hypomethylation-Linked Activation of PLCE1 Impedes
    Published OnlineFirst February 17, 2020; DOI: 10.1158/0008-5472.CAN-19-1912 CANCER RESEARCH | MOLECULAR CELL BIOLOGY Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53 Yunzhao Chen1,2, Huahua Xin1, Hao Peng1, Qi Shi1, Menglu Li1,JieYu2, Yanxia Tian1, Xueping Han1, Xi Chen1, Yi Zheng3,JunLi4, Zhihao Yang1, Lan Yang1, Jianming Hu1, Xuan Huang5, Zheng Liu5, Xiaoxi Huang5, Hong Zhou6, Xiaobin Cui1, and Feng Li1,5 ABSTRACT ◥ Esophageal squamous cell carcinoma (ESCC) is one of the dead- Significance: These findings identify hypomethylation- liest malignant diseases. Multiple studies with large clinic-based mediated activation of PLCE1 as a potential oncogene that cohorts have revealed that variations of phospholipase C epsilon 1 blocks cellular autophagy of esophageal carcinoma by facilitat- (PLCE1) correlate with esophageal cancer susceptibility. However, ing the MDM2-dependent ubiquitination of p53 and subsequent the causative role of PLCE1 in ESCC has remained elusive. Here, we degradation. observed that hypomethylation-mediated upregulation of PLCE1 Graphical Abstract: http://cancerres.aacrjournals.org/content/ expression was implicated in esophageal carcinogenesis and poor canres/80/11/2175/F1.large.jpg. prognosis in ESCC cohorts. PLCE1 inhibited cell autophagy and suppressed the protein expression of p53 and various p53-targeted genes in ESCC. Moreover, PLCE1 decreased the half-life of p53 and Normal cells Cancer cells promoted p53 ubiquitination, whereas it increased the half-life of PLCE1 Cytoplasm Cytoplasm mouse double minute 2 homolog (MDM2) and inhibited its ubiqui- wtp53 wtp53 tination, leading to MDM2 stabilization. Mechanistically, the func- MDM2 MDM2 wtp53 MDM2 MDM2 Nucleus tion of PLCE1 correlated with its direct binding to both p53 and Nucleus wtp53 Ub Ub MDM2, which promoted MDM2-dependent ubiquitination of p53 PLCE1 MDM2 wtp53 Ub wtp53 wtp53 and subsequent degradation in vitro.
    [Show full text]
  • Some Ultrastructural and Enzymatic Effects of Water Stress in Cotton (Gossypium Hirsutum L.) Leaves (Acid Phosphatase/Acid Lipase/Alkaline Lipase)
    Proc. Nat. Acad. Sci. USA Vol. 71, No. 8, pp. 3243-3247, August 1974 Some Ultrastructural and Enzymatic Effects of Water Stress in Cotton (Gossypium hirsutum L.) Leaves (acid phosphatase/acid lipase/alkaline lipase) JORGE VIEIRA DA SILVA*, AUBREY W. NAYLOR, AND PAUL J. KRAMER Department of Botany, Duke University, Durham, North Carolina 27706 Contributed by Paul J. Kramer, May 30, 1974 ABSTRACT Water stress induced by floating discs cut boxylation of glycine occurs after lipase treatment of mito- from cotton leaves (Gossypium hirsutum L. cultivar chondria Stoneville) on a polyethylene glycol solution (water poten- (23). tial, -10 bars) was associated with marked alteration of Results, thus far obtained by indirect means, support the ultrastructural organization of both chloroplasts and hypothesis that water stress in drought sensitive species leads mitochondria. Ultrastructural organization of chloro- to hydrolytic activity that degrades not only storage products plasts was sometimes almost completely destroyed; per- but the structural framework of organelles such as ribosomes, oxisomes seemed not to be affected; and chloroplast ribosomes disappeared. Also accompanying water stress chloroplasts, and mitochondria. Ultrastructural and micro- was a sharp increase in activity of acid phosphatase chemical evidence is reported here that such deterioration [orthoplhosphoric-monoester phosplhohydrolase (acid opti- occurs in cotton (Gossypium hirsutum L. cv. Stoneville) during mum), EC 3.1.3.2], and acid and alkaline lipase [glycerol water stress. ester hydrolase EC 3.1.1.3] within chloroplasts. Only acid lipase activity was detected inside mitochondria of stressed MATERIALS AND METHODS discs. These alterations in cell organization and enzy- mology may account for at least part of the previously Cotton plants (Gossypium hirsutum L.
    [Show full text]
  • The Characterization of Oligonucleotides and Nucleic Acids Using Ribonuclease H and Mass Spectrometry
    Louisiana State University LSU Digital Commons LSU Historical Dissertations and Theses Graduate School 1999 The hC aracterization of Oligonucleotides and Nucleic Acids Using Ribonuclease H and Mass Spectrometry. Lenore Marie Polo Louisiana State University and Agricultural & Mechanical College Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_disstheses Recommended Citation Polo, Lenore Marie, "The hC aracterization of Oligonucleotides and Nucleic Acids Using Ribonuclease H and Mass Spectrometry." (1999). LSU Historical Dissertations and Theses. 6923. https://digitalcommons.lsu.edu/gradschool_disstheses/6923 This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Historical Dissertations and Theses by an authorized administrator of LSU Digital Commons. For more information, please contact [email protected]. INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter free, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion. Oversize materials (e.g., maps, drawings, charts) are reproduced by sectioning the original, beginning at the upper left-hand corner and continuing from left to right in equal sections with small overlaps.
    [Show full text]
  • Juvenile Hormone-Activated Phospholipase C Pathway PNAS PLUS Enhances Transcriptional Activation by the Methoprene-Tolerant Protein
    Juvenile hormone-activated phospholipase C pathway PNAS PLUS enhances transcriptional activation by the methoprene-tolerant protein Pengcheng Liua, Hong-Juan Pengb, and Jinsong Zhua,1 aDepartment of Biochemistry, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061; and bDepartment of Pathogen Biology, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, Guangdong, 510515, China Edited by Lynn M. Riddiford, Howard Hughes Medical Institute Janelia Farm Research Campus, Ashburn, VA, and approved March 11, 2015 (received for review December 4, 2014) Juvenile hormone (JH) is a key regulator of a wide diversity of in the regulatory regions of JH-responsive genes, leading to developmental and physiological events in insects. Although the the transcriptional activation of these genes (12). This function intracellular JH receptor methoprene-tolerant protein (MET) func- of MET–TAI in the JH-induced gene expression seems to be tions in the nucleus as a transcriptional activator for specific JH- evolutionarily conserved in Ae. aegypti, D. melanogaster, the red regulated genes, some JH responses are mediated by signaling flour beetle Tribolium castaneum, the silkworm Bombyx mori,and pathways that are initiated by proteins associated with plasma the cockroach Bombyx mori (9, 13–16). membrane. It is unknown whether the JH-regulated gene expres- The mechanisms by which JH exerts pleiotropic functions are sion depends on the membrane-mediated signal transduction. In manifold in insects. Several studies suggest that JH can act via a Aedes aegypti mosquitoes, we found that JH activated the phos- receptor on plasma membrane (3, 17). For example, develop- pholipase C (PLC) pathway and quickly increased the levels of ino- ment of ovarian patency during vitellogenesis is stimulated by JH sitol 1,4,5-trisphosphate, diacylglycerol, and intracellular calcium, in some insects via transmembrane signaling cascades that in- leading to activation and autophosphorylation of calcium/calmod- volve second messengers (18, 19).
    [Show full text]